WallStSmart
CVRX

CVRx Inc

NASDAQ: CVRX · HEALTHCARE · MEDICAL DEVICES

$5.27
-8.50% today

Updated 2026-06-05

Market cap
$156.03M
P/E ratio
P/S ratio
2.64x
EPS (TTM)
$-2.01
Dividend yield
52W range
$4 – $11
Volume
0.3M

CVRx Inc (CVRX) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item2019202020212022202320242025
Revenue$6.26M$6.05M$13.04M$22.47M$39.30M$51.29M$56.65M
Revenue growth (YoY)-3.3%+115.4%+72.4%+74.9%+30.5%+10.4%
Cost of revenue$1.68M$1.44M$3.64M$5.00M$6.26M$8.33M$8.31M
Gross profit$4.57M$4.61M$9.40M$17.47M$33.04M$42.96M$48.34M
Gross margin73.1%76.2%72.1%77.8%84.1%83.8%85.3%
R&D$8.66M$6.41M$7.50M$9.95M$11.63M$11.13M$11.13M
SG&A$6.11M$9.72M$27.86M$50.05M$61.60M$91.32M$88.47M
Operating income$-10.19M$-11.51M$-25.97M$-42.53M$-43.10M$-59.49M$-51.27M
Operating margin-162.9%-190.2%-199.2%-189.3%-109.7%-116.0%-90.5%
EBITDA$-12.78M$-11.48M$-40.60M$-40.74M$-43.10M$-54.89M$-46.74M
EBITDA margin-204.3%-189.6%-311.4%-181.3%-109.7%-107.0%-82.5%
EBIT$-12.84M$-11.55M$-40.77M$-41.15M$-43.10M$-55.51M$-47.50M
Interest expense$1.72M$2.47M$2.22M$165000.00$1.80M$4.40M$5.83M
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-14.63M$-14.11M$-43.08M$-41.43M$-41.20M$-59.97M$-53.31M
Net income growth (YoY)+3.6%-205.3%+3.8%+0.6%-45.5%+11.1%
Profit margin-233.9%-233.1%-330.5%-184.4%-104.8%-116.9%-94.1%

Frequently asked questions

What is CVRx Inc's revenue?

CVRx Inc's trailing twelve-month revenue is $59.07M. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is CVRX?

In its most recent fiscal year, CVRX ran a gross margin of 85.33%, an operating margin of -90.49%, and a net margin of -94.10%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does CVRX generate?

CVRX produced $-40.75M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is CVRX's balance sheet healthy?

CVRX holds $75.71M in cash and equivalents against $49.51M in long-term debt, on $39.32M of shareholder equity. Cash on hand exceeds long-term debt, so the balance sheet adds little financial risk to the thesis.